Name of this trial: Destiny-BTC What type of cancer is this for? Biliary Tract Cancer Who is this trial for? First line for locally advanced or metastatic HER2 expressing biliary tract cancer What biomarkers are involved? HER2 positive (expressing) What is the National Clinical Trial #? NCT06467357 Brief summary of this trial: Phase 3
Archives: Clinical Trials
Breast
Name of this trial: MK-2870-011 (TroFuse-011) What type of cancer is this for? Triple-Negative Breast Cancer Who is this trial for? Patients With Previously Untreated Locally Recurrent Unresectable or Metastatic Triple-Negative Breast Cancer What biomarkers are involved? Expressing PD-L1 at CPS Less Than 10 What is the National Clinical Trial #? NCT06841354; https://clinicaltrials.gov/study/NCT06841354 Brief summary of this trial: A Phase 3, Randomized, Open-label
Colorectal
Name of this trial: Symbiotic-GI-03 What type of cancer is this for? Metastatic colorectal cancer Who is this trial for? Patients with treatment-naiive metastatic colorectal cancer What biomarkers are involved? N/A What is the National Clinical Trial #? NCT07222800 https://clinicaltrials.gov/study/NCT07222800 Brief summary of this trial: AN INTERVENTIONAL, PHASE 3, DOUBLE-BLIND, RANDOMIZED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PF-08634404
Esophageal
NAME: GEMINI GASTRIC What type of cancer is this for? Stomach and where the stomach and esophagus join together Phase: II Who is this trial for: Men and women who have stomach cancer, or cancer where the stomach and esophagus meet, that cannot be removed or has spread to other parts of the body What
Gallbladder
NAME: PanTumor3- Biliary Tree What type of cancer is this for: Liver, gallbladder, bile ducts Phase: II Who is this trial for: Men and women who have cancer in their biliary tract: liver and/or gallbladder and/or bile ducts that has spread to other parts of the body and cannot be taken out. What biomarkers are
Gastric
Name of this trial: CLARITY-Gastric02 What type of cancer is this for? Advanced/Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing CLDN 18.2 Who is this trial for? Subjects With Previously Untreated, Locally Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma What biomarkers are involved? Positive expression of Claudin 18.2 What is the National Clinical
Hematology
Kidney
Name of this trial: Artemide-HCC01 What type of cancer is this for? Advanced Hepatocellular Cancer Who is this trial for? Patients who have advanced kidney cancer that have not had prior treatment in advanced setting. What biomarkers are involved? Central PD-L1 testing, however positivity not dependent on inclusivity What is the National Clinical Trial #?
Leukemia
Name of this trial: BGB-11417-303/CLL-RR1 What type of cancer is this for? Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Who is this trial for? Relapsed and/or Refractory What biomarkers are involved? CLL Cytogenics (eg, del(17p), del(11q), del(13q), and trisomy 12), complex karyotype, and the mutational status of relevant genes such as IGHV, TP53, and other CLL-related prognosis
Liver
NAME: PanTumor3- Biliary Tree What type of cancer is this for: Liver, gallbladder, bile ducts Phase: II Who is this trial for: Men and women who have cancer in their biliary tract: liver and/or gallbladder and/or bile ducts that has spread to other parts of the body and cannot be taken out. What biomarkers are